Confirmatory Study of Time-Dependent Computed Tomographic Perfusion Thresholds for Use in Acute Ischemic Stroke.


Journal

Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266

Informations de publication

Date de publication:
11 2019
Historique:
pubmed: 5 9 2019
medline: 1 4 2020
entrez: 5 9 2019
Statut: ppublish

Résumé

Background and Purpose- Computed tomographic perfusion (CTP) thresholds associated with follow-up brain infarction may differ by time from symptom onset to imaging and reperfusion. We confirm CTP thresholds over time to imaging and reperfusion in patients with acute ischemic stroke from the HERMES collaboration (Highly Effective Reperfusion Evaluated in Multiple Endovascular Stroke Trials) data. Methods- Patients with occlusion on CT angiography were acutely imaged with CTP. Noncontrast CT and magnetic resonance-diffusion weighted imaging at 24 to 48 hours defined follow-up infarction. Reperfusion was assessed on conventional angiogram. Tmax, cerebral blood flow (CBF), and cerebral blood volume maps were derived from delay-insensitive CTP postprocessing. These parameters were analyzed using receiver operator characteristics to derive optimal thresholds based on time from stroke onset-to-CTP or to reperfusion. ANOVA and linear regression were used to test whether the derived CTP thresholds were different by time. Results- One hundred thirty-seven patients were included. Tmax thresholds of >15.7 s and >15.8 s and absolute CBF thresholds of <8.9 and <7.5 mL·min

Identifiants

pubmed: 31480968
doi: 10.1161/STROKEAHA.119.026281
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3269-3273

Subventions

Organisme : Department of Health
ID : HTA/14/08/47
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Wu Qiu (W)

From the Department of Clinical Neurosciences (W.Q., H.K., M.D.H., A.M.D., M.G., B.K.M.), University of Calgary.

Hulin Kuang (H)

From the Department of Clinical Neurosciences (W.Q., H.K., M.D.H., A.M.D., M.G., B.K.M.), University of Calgary.

Ting Y Lee (TY)

Lawson Health Research Institute and Robarts Research Institute (T.Y.L.).

Anna M Boers (AM)

Department of Biomedical Engineering and Physics (A.M.B.), Amsterdam University Medical Centers.

Scott Brown (S)

Altair Biostatistics, Mooresville, NC (S.B.).

Keith Muir (K)

Institute of Neuroscience and Psychology, University of Glasgow, Queen Elizabeth University Hospital (K.M.).

Charles B L M Majoie (CBLM)

Department of Radiology and Nuclear Medicine (C.B.L.M.M.), Amsterdam University Medical Centers.

Diederik W J Dippel (DWJ)

Department of Neurology, Erasmus University Medical Center (D.W.J.D.).

Phil White (P)

Institute of Neuroscience, Newcastle University (P.W.).

Francis Guillemin (F)

Centre Hospitalier Régional et Universitaire de Nancy, Université de Lorraine (F.G.).

Peter J Mitchell (PJ)

Department of Radiology (P.J.M.), Royal Melbourne Hospital, University of Melbourne.

Antoni Dávalos (A)

Department of Neuroscience, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona (A.D.).

Serge Bracard (S)

Department of Diagnostic and Interventional Neuroradiology, University of Lorraine and University Hospital of Nancy (S.B.).

Bruce Campbell (B)

Department of Medicine and Neurology (B.C.), Royal Melbourne Hospital, University of Melbourne.

Jeffrey L Saver (JL)

David Geffen School of Medicine, University of Los Angeles (J.L.S.).

Tudor G Jovin (TG)

Cooper Neurological Institute (T.G.J.).

Michael D Hill (MD)

From the Department of Clinical Neurosciences (W.Q., H.K., M.D.H., A.M.D., M.G., B.K.M.), University of Calgary.
Department of Radiology (M.D.H., A.M.D., M.G., B.K.M.), University of Calgary.
Hotchkiss Brain Institute (M.D.H., A.M.D., M.G., B.K.M.), University of Calgary.

Andrew M Demchuk (AM)

From the Department of Clinical Neurosciences (W.Q., H.K., M.D.H., A.M.D., M.G., B.K.M.), University of Calgary.
Department of Radiology (M.D.H., A.M.D., M.G., B.K.M.), University of Calgary.
Hotchkiss Brain Institute (M.D.H., A.M.D., M.G., B.K.M.), University of Calgary.

Mayank Goyal (M)

From the Department of Clinical Neurosciences (W.Q., H.K., M.D.H., A.M.D., M.G., B.K.M.), University of Calgary.
Department of Radiology (M.D.H., A.M.D., M.G., B.K.M.), University of Calgary.
Hotchkiss Brain Institute (M.D.H., A.M.D., M.G., B.K.M.), University of Calgary.

Bijoy K Menon (BK)

From the Department of Clinical Neurosciences (W.Q., H.K., M.D.H., A.M.D., M.G., B.K.M.), University of Calgary.
Department of Radiology (M.D.H., A.M.D., M.G., B.K.M.), University of Calgary.
Hotchkiss Brain Institute (M.D.H., A.M.D., M.G., B.K.M.), University of Calgary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH